We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sample Preparation for Molecular Diagnostics

By HospiMedica staff writers
Posted on 11 Oct 2005
A new sample preparation platform represents a new solution for nucleic acid isolation, quantification, normalization, and reaction set-up for downstream assay analysis.

Called Vidiera NsP, the platform is based on the Biomek automation and diagnostic primary tube-handling technologies of Beckman Coulter (Fullerton, CA, USA) and is specifically designed to meet the growing need for molecular testing in hospital and reference laboratories.

Vidiera can be used for molecular diagnostic applications in virology and pathology and can be integrated with Beckman Coulter's Vidiera NsD nucleic sample detection system. More...
Vidiera NsP can be used for setting-up reactions for most major downstream analytical instruments that molecular diagnostic laboratories have today, while Vidiera NsD enables labs to centralize pre-analytic functions in one room and to streamline the process. Vidiera NsP will be marketed to high-complexity diagnostic laboratories.

"Our new Vidiera products bring together our expertise in clinical diagnostics and research laboratory automation to benefit the growing field of molecular testing,” explained Bruce Wallace, vice president, nucleic acid testing business, Beckman Coulter.
"This product line is a clear example of our biomedical testing continuum strategy and demonstrates the advantage our broad range of expertise gives us in bringing new solutions to the diagnostic workplace.”

Beckman Coulter has more than 200,000 installed systems around the world that span the biomedical testing continuum from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing.




Related Links:
Beckman Coulter

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.